ZA86949B - Dopamine-beta-hydroxylase inhibitors - Google Patents
Dopamine-beta-hydroxylase inhibitorsInfo
- Publication number
- ZA86949B ZA86949B ZA86949A ZA86949A ZA86949B ZA 86949 B ZA86949 B ZA 86949B ZA 86949 A ZA86949 A ZA 86949A ZA 86949 A ZA86949 A ZA 86949A ZA 86949 B ZA86949 B ZA 86949B
- Authority
- ZA
- South Africa
- Prior art keywords
- dopamine
- beta
- hydroxylase inhibitors
- hydroxylase
- inhibitors
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/18—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms
- C07C331/22—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C331/24—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/700,234 US4707488A (en) | 1985-02-11 | 1985-02-11 | Dopamine-β-hydroxylase inhibitors and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA86949B true ZA86949B (en) | 1986-09-24 |
Family
ID=24812701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA86949A ZA86949B (en) | 1985-02-11 | 1986-02-10 | Dopamine-beta-hydroxylase inhibitors |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4707488A (es) |
| EP (1) | EP0191621A3 (es) |
| JP (1) | JPS61183274A (es) |
| AU (2) | AU590538B2 (es) |
| CA (1) | CA1271767A (es) |
| DK (1) | DK62086A (es) |
| ES (1) | ES8706651A1 (es) |
| GR (1) | GR860362B (es) |
| PT (1) | PT81973B (es) |
| ZA (1) | ZA86949B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9510481D0 (en) * | 1995-05-24 | 1995-07-19 | Orion Yhtymae Oy | New catechol derivatives |
| CN105061254A (zh) * | 2015-07-20 | 2015-11-18 | 湖南华腾制药有限公司 | 一种含溴叠氮化合物的合成方法 |
| CN105153020A (zh) * | 2015-07-20 | 2015-12-16 | 湖南华腾制药有限公司 | 一种芳香叠氮化合物的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2386869A (en) * | 1945-10-16 | Manufacture of | ||
| DE1251327B (de) * | 1964-10-26 | 1967-10-05 | Eastman Kodak Company, Rochester, NY (V St A) | Verfahren zur Her Stellung von in 5 Stellung substituierten 1 Aryl-lH-tetrazolen |
| JPS4923367B1 (es) * | 1970-03-20 | 1974-06-15 | ||
| US4110338A (en) * | 1973-10-31 | 1978-08-29 | Fujisawa Pharmaceutical Co., Ltd. | Product and preparation of 1H-tetrazole-5-thiol derivatives |
| PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
-
1985
- 1985-02-11 US US06/700,234 patent/US4707488A/en not_active Expired - Fee Related
-
1986
- 1986-02-04 CA CA000501062A patent/CA1271767A/en not_active Expired - Lifetime
- 1986-02-04 AU AU52975/86A patent/AU590538B2/en not_active Ceased
- 1986-02-05 PT PT81973A patent/PT81973B/pt not_active IP Right Cessation
- 1986-02-07 DK DK62086A patent/DK62086A/da unknown
- 1986-02-07 GR GR860362A patent/GR860362B/el unknown
- 1986-02-10 ES ES551792A patent/ES8706651A1/es not_active Expired
- 1986-02-10 JP JP61027737A patent/JPS61183274A/ja active Pending
- 1986-02-10 ZA ZA86949A patent/ZA86949B/xx unknown
- 1986-02-10 EP EP86300898A patent/EP0191621A3/en not_active Withdrawn
-
1989
- 1989-08-21 AU AU40106/89A patent/AU4010689A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US4707488A (en) | 1987-11-17 |
| JPS61183274A (ja) | 1986-08-15 |
| DK62086A (da) | 1986-08-12 |
| PT81973A (en) | 1986-03-01 |
| AU590538B2 (en) | 1989-11-09 |
| PT81973B (pt) | 1988-07-01 |
| ES8706651A1 (es) | 1987-07-01 |
| EP0191621A2 (en) | 1986-08-20 |
| CA1271767A (en) | 1990-07-17 |
| DK62086D0 (da) | 1986-02-07 |
| EP0191621A3 (en) | 1988-06-22 |
| ES551792A0 (es) | 1987-07-01 |
| AU4010689A (en) | 1989-12-07 |
| AU5297586A (en) | 1986-08-14 |
| GR860362B (en) | 1986-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3662194D1 (en) | Lipoxygenase inhibitors | |
| ZA884838B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83076A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA883851B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83628B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT85081A (en) | Irreversible dopamine-beta-hydroxylase inhibitors | |
| ZA889667B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA889709B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA873653B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT85596A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA8892B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA882100B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83626A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA86949B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA863425B (en) | 2-substituted-1-naphthols as 5-lipoxygenase inhibitors | |
| ZA842962B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA842963B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZW4285A1 (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA882275B (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE852330L (en) | Ó-d-mannosidase inhibitor | |
| IE852172L (en) | L - glucosidase inhibitor | |
| CS74285A1 (en) | Smesny vyparovaci inhibitor koroze kovu | |
| IE880860L (en) | Dopamine-beta-hydroxylase inhibitors | |
| CS74385A1 (en) | Inhibitor koroze kovu pro prostredky docasne ochrany | |
| IL103617A0 (en) | Growth inhibitor tgi-2 |